A detailed history of South Dakota Investment Council transactions in Pfizer Inc stock. As of the latest transaction made, South Dakota Investment Council holds 1,339,986 shares of PFE stock, worth $34.4 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
1,339,986
Previous 1,294,741 3.49%
Holding current value
$34.4 Million
Previous $36.2 Million 7.04%
% of portfolio
0.76%
Previous 0.74%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$27.7 - $31.39 $1.25 Million - $1.42 Million
45,245 Added 3.49%
1,339,986 $38.8 Million
Q2 2024

Aug 08, 2024

BUY
$25.26 - $29.6 $239,641 - $280,815
9,487 Added 0.74%
1,294,741 $36.2 Million
Q1 2024

May 02, 2024

BUY
$25.89 - $29.73 $999,509 - $1.15 Million
38,606 Added 3.1%
1,285,254 $35.7 Million
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $8.16 Million - $10.6 Million
312,410 Added 33.44%
1,246,648 $35.9 Million
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $2.69 Million - $3.14 Million
83,823 Added 9.86%
934,238 $31 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $1.57 Million - $1.81 Million
-43,362 Reduced 4.85%
850,415 $31.2 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $3.6 Million - $4.68 Million
91,300 Added 11.38%
893,777 $36.5 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $645,329 - $842,406
-15,457 Reduced 1.89%
802,477 $41.1 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $258,184 - $315,178
5,900 Added 0.73%
817,934 $35.8 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $2.44 Million - $2.89 Million
52,456 Added 6.91%
812,034 $42.6 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $11.9 Million - $14.7 Million
-259,335 Reduced 25.45%
759,578 $39.3 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $2.74 Million - $4.07 Million
-66,400 Reduced 6.12%
1,018,913 $60.2 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $569,125 - $731,090
-14,500 Reduced 1.32%
1,085,313 $46.7 Million
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $6.13 Million - $6.95 Million
-170,770 Reduced 13.44%
1,099,813 $43.1 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $1.41 Million - $1.59 Million
42,006 Added 3.42%
1,270,583 $46 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $3.28 Million - $4.17 Million
-98,000 Reduced 7.39%
1,228,577 $45.2 Million
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $3.38 Million - $3.96 Million
-106,440 Reduced 7.43%
1,326,577 $48.7 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $643,965 - $781,225
21,380 Added 1.51%
1,433,017 $46.9 Million
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $5.97 Million - $8.53 Million
220,742 Added 18.54%
1,411,637 $46.1 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $5.13 Million - $5.82 Million
-155,830 Reduced 11.57%
1,190,895 $46.7 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $500,021 - $648,380
15,390 Added 1.16%
1,346,725 $48.4 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $1.93 Million - $2.17 Million
-52,280 Reduced 3.78%
1,331,335 $57.7 Million
Q1 2019

May 03, 2019

BUY
$37.5 - $41.2 $1.95 Million - $2.14 Million
52,018 Added 3.91%
1,383,615 $58.8 Million
Q4 2018

Feb 06, 2019

SELL
$38.47 - $43.86 $3.02 Million - $3.44 Million
-78,460 Reduced 5.56%
1,331,597 $58.1 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $9.33 Million - $11.3 Million
-270,650 Reduced 16.1%
1,410,057 $62.1 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $5.24 Million - $5.59 Million
-158,960 Reduced 8.64%
1,680,707 $61 Million
Q1 2018

May 10, 2018

SELL
$31.91 - $37.02 $1.2 Million - $1.39 Million
-37,534 Reduced 2.0%
1,839,667 $65.3 Million
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $13.5 Million - $14.3 Million
-404,490 Reduced 17.73%
1,877,201 $68 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $70.7 Million - $77.9 Million
2,281,691
2,281,691 $81.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track South Dakota Investment Council Portfolio

Follow South Dakota Investment Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.